Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KDM2B | Q8NHM5 | 11/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29155928 | 0.97 | ALDH1A1 (0.42) | MEN1KMT2AALDH1A1SMN1; SMN2KDM2B | |
| SCHEMBL2577531 | 0.94 | MEN1 (0.38) | MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL1307428 | 0.89 | ALDH1A1 (0.40) | MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL1307534 | 0.87 | CCR5 (0.35) | MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL988772 | 0.84 | ALDH1A1 (0.39) | MEN1KMT2AALDH1A1KDM2BSIGMAR1 | |
| SCHEMBL1306995 | 0.81 | ALDH1A1 (0.42) | MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL2694217 | 0.79 | MEN1 (0.38) | MEN1KMT2ASIGMAR1 | |
| SCHEMBL2694220 | 0.79 | MEN1 (0.38) | MEN1KMT2ASIGMAR1 | |
| SCHEMBL1306189 | 0.77 | ALDH1A1 (0.35) | MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL20377502 | 0.75 | ALDH1A1 (0.41) | ALDH1A1KDM2BBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118234711-A | Cyclopyridazine compounds | 尼科治疗有限公司 | 2024-06-21 | — | — | CN | disclosed |